The emerging therapy of the medication represents a significant advance in the care of type 2 diabetes. Different to existing medications, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide305421.goabroadblog.com/40727351/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment